SEC Form 4 · accession 0001214659-18-003060
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Isan Chen
Officer — EVP, Chief Medical Officer
Period of report
Apr 25, 2018
Accepted (ET)
Apr 26, 2018 · 6:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 25, 2018 | M | 2 | $5.40 | A | 18,800 | D | |
| Common Stock | Apr 25, 2018 | M | 10,124 | $15.79 | A | 28,924 | D | |
| Common Stock | Apr 25, 2018 | M | 412 | $17.41 | A | 29,336 | D | |
| Common Stock | Apr 25, 2018 | M | 2,500 | $21.51 | A | 31,836 | D | |
| Common Stock | holding | — | — | — | 110 | I | By Chen Living Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $5.40 | Apr 25, 2018 | M | 2 | D | — | Jan 25, 2027 | Common Stock | 2 | 49,998 | D |
| Employee Stock Option (Right to Buy)F1 | $15.79 | Apr 25, 2018 | M | 10,124 | D | — | Nov 7, 2023 | Common Stock | 10,124 | 96,668 | D |
| Employee Stock Option (Right to Buy)F1 | $17.41 | Apr 25, 2018 | M | 412 | D | — | May 20, 2024 | Common Stock | 412 | 6,188 | D |
| Employee Stock Option (Right to Buy)F1 | $21.51 | Apr 25, 2018 | M | 2,500 | D | — | Feb 3, 2025 | Common Stock | 2,500 | 27,500 | D |
Explanation of responses
- F11/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.